Anonymous
Guest
Anonymous
Guest
Simple scenario - two reps in the same geography and Rep #1 promotes Reclast, Exelon Patch and has Diovan in the 3rd spot, Rep #2 has cardiovascular line products only. Both reps have had equivalent performance reviews for the past several years and neither has had a "1" for the past several years and neither expects a "1" on the 2011 review. Rep #1 has 4 years with Novartis and Rep #2 has 8 years. Rep #1 has been effective in the territory with the products that will continue to be promoted for the balance of 2012, Rep #2 will need to be trained on Reclast and Exelon Patch if retained. So based on this scenario, will Rep #2 win out based on seniority or will Rep #1 be retained based upon what that rep is already selling?